These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6212203)

  • 21. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
    Giron JA; Meyers BR; Hirschman SZ; Srulevitch E
    Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition kinetics and bioavailability of piperacillin and cephapirin in mares.
    el-Komy AA
    Dtsch Tierarztl Wochenschr; 1995 Jun; 102(6):244-8. PubMed ID: 8582260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].
    Baier R; Puppel H; Zelder O; Zehner R
    Arzneimittelforschung; 1981; 31(5):857-61. PubMed ID: 6456008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.
    Bulitta JB; Duffull SB; Kinzig-Schippers M; Holzgrabe U; Stephan U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2497-507. PubMed ID: 17485505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function.
    Lau A; Lee M; Flascha S; Prasad R; Sharifi R
    Antimicrob Agents Chemother; 1983 Oct; 24(4):533-7. PubMed ID: 6651279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Safety and pharmacology of aspoxicillin in healthy volunteers].
    Matsumoto K; Shishido H; Uzuka Y; Nagatake T; Yamamoto M; Sakuma Y; Maezawa I; Yamaguchi T
    Jpn J Antibiot; 1985 Oct; 38(10):2699-715. PubMed ID: 4078992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of piperacillin in hospitalized patients.
    Lau A; Lee M; Sharifi R
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):391-4. PubMed ID: 4044070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of piperacillin on pharmacokinetics of etimicin in healthy volunteers.
    Wang HX; Zhang LR; Ma XC; Ma TX
    Acta Pharmacol Sin; 2002 Apr; 23(4):376-80. PubMed ID: 11931698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of free extracellular concentrations of piperacillin by microdialysis.
    Nolting A; Costa TD; Vistelle R; Rand KH; Derendorf H
    J Pharm Sci; 1996 Apr; 85(4):369-72. PubMed ID: 8901070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of mezlocillin in healthy volunteers.
    Bergan T
    Antimicrob Agents Chemother; 1978 Dec; 14(6):801-6. PubMed ID: 742869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative pharmacokinetics of piperacillin during liver transplantation.
    Bourget P; Lesne-Hulin A; Ecoffey C; Levaufre B
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):550-4. PubMed ID: 8996851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.